These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21800532)

  • 1. [Multidrug resistance-associated proteins and their roles in multidrug resistance].
    Zhang H; Fu LW
    Yao Xue Xue Bao; 2011 May; 46(5):479-86. PubMed ID: 21800532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance-associated proteins and implications in drug development.
    Liu YH; Di YM; Zhou ZW; Mo SL; Zhou SF
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):115-20. PubMed ID: 19566819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug Resistance Proteins (MRPs) and Cancer Therapy.
    Zhang YK; Wang YJ; Gupta P; Chen ZS
    AAPS J; 2015 Jul; 17(4):802-12. PubMed ID: 25840885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in cancer: its mechanism and its modulation.
    Pauwels EK; Erba P; Mariani G; Gomes CM
    Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets.
    Nagengast WB; Oude Munnink TH; Dijkers EC; Hospers GA; Brouwers AH; Schröder CP; Lub-de Hooge M; de Vries EG
    Methods Mol Biol; 2010; 596():15-31. PubMed ID: 19949918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance associated proteins in multidrug resistance.
    Sodani K; Patel A; Kathawala RJ; Chen ZS
    Chin J Cancer; 2012 Feb; 31(2):58-72. PubMed ID: 22098952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.
    Jaiswal R; Raymond Grau GE; Bebawy M
    Future Oncol; 2014 Mar; 10(4):655-69. PubMed ID: 24754595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.
    Meijerman I; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2008 Oct; 34(6):505-20. PubMed ID: 18413281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
    Konings WN; Poelarends GJ
    IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells.
    Koshkin V; Krylov SN
    Anal Chem; 2011 Aug; 83(16):6132-4. PubMed ID: 21770449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRP1 and its role in anticancer drug resistance.
    Lu JF; Pokharel D; Bebawy M
    Drug Metab Rev; 2015; 47(4):406-19. PubMed ID: 26541366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance in cancer: role of ATP-dependent transporters.
    Gottesman MM; Fojo T; Bates SE
    Nat Rev Cancer; 2002 Jan; 2(1):48-58. PubMed ID: 11902585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug transporters and their role in multidrug resistance of neoplastic cells.
    Kvackajová-Kisucká J; Barancík M; Breier A
    Gen Physiol Biophys; 2001 Sep; 20(3):215-37. PubMed ID: 11765214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
    Chang XB
    Methods Mol Biol; 2010; 596():223-49. PubMed ID: 19949927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
    Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
    Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM
    Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.
    Chen ZS; Tiwari AK
    FEBS J; 2011 Sep; 278(18):3226-45. PubMed ID: 21740521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Modeling Strategies of Cancer Multidrug Resistance.
    Yalcin-Ozkat G
    Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of sildenafil in enhancing drug sensitivity in cancer.
    Shi Z; Tiwari AK; Patel AS; Fu LW; Chen ZS
    Cancer Res; 2011 Jun; 71(11):3735-8. PubMed ID: 21610107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.